FDA Spanks J&J McNeil Plant Over Complaint Failures
Last month new CEO Gorsky told shareholders he would move J&J past consumer issues
In other words J&J didn't walk the walk.
- read the warning letter here
- see Bloomberg's (nj.com) take
Fixing OTC production problems is a top priority for new J&J CEO
Executive suite not spared in J&J reorg tied to quality concerns
Thank You FiercePharmaManufacturing and Mr Palmer